A Nature analysis reveals the 25 highest-cited papers published this century and explores why they are breaking records.

Science Tokyo will introduce a new vision-driven integrated research framework across the Institute in April 2025 to create enhanced societal impact across various key areas. Driving the model forward ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive supercomputer will give it the edge to dominate the sector.

DOPE-Cx can form a special structure called a "cubic phase," which helps overcome a major challenge in mRNA delivery by LNPs: endosomal escape. LNPs are taken into the cell in the form of ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

By altering the mRNA structure, researchers can create stable, non-immunogenic mRNA through in vitro transcription. Furthermore, effective delivery strategies tailored specifically for mRNA are ...

Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for ...

Beyond this, Moderna’s pipeline also includes other promising latent vaccines, such as the Cytomegalovirus (CMV) vaccine (mRNA-1647), which is currently in Phase 3, as well as vaccines targeting ...

The most recent trading session ended with Moderna (MRNA) standing at $24.73, reflecting a -1.85% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...